BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23884042)

  • 21. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.
    McDade E; Wang G; Gordon BA; Hassenstab J; Benzinger TLS; Buckles V; Fagan AM; Holtzman DM; Cairns NJ; Goate AM; Marcus DS; Morris JC; Paumier K; Xiong C; Allegri R; Berman SB; Klunk W; Noble J; Ringman J; Ghetti B; Farlow M; Sperling RA; Chhatwal J; Salloway S; Graff-Radford NR; Schofield PR; Masters C; Rossor MN; Fox NC; Levin J; Jucker M; Bateman RJ;
    Neurology; 2018 Oct; 91(14):e1295-e1306. PubMed ID: 30217935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.
    Jiao B; Tang B; Liu X; Xu J; Wang Y; Zhou L; Zhang F; Yan X; Zhou Y; Shen L
    Neurobiol Aging; 2014 Aug; 35(8):1957.e1-6. PubMed ID: 24650794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
    Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
    JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.
    Day GS; Musiek ES; Roe CM; Norton J; Goate AM; Cruchaga C; Cairns NJ; Morris JC
    JAMA Neurol; 2016 Sep; 73(9):1125-32. PubMed ID: 27454811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
    Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving brain functional abnormalities in PSEN1 mutation carriers: a resting and visual encoding fMRI study.
    Sala-Llonch R; Fortea J; Bartrés-Faz D; Bosch B; Lladó A; Peña-Gómez C; Antonell A; Castellanos-Pinedo F; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2013; 36(1):165-75. PubMed ID: 23579331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden.
    Schultz AP; Buckley RF; Hampton OL; Scott MR; Properzi MJ; Peña-Gómez C; Pruzin JJ; Yang HS; Johnson KA; Sperling RA; Chhatwal JP
    Neuroimage Clin; 2020; 26():102052. PubMed ID: 31711955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetics of dementias, Part 4: a spectrum of mutations responsible for the familial autosomal dominant form of Alzheimer's disease].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():583-91. PubMed ID: 20009122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in Finnish patients with early-onset Alzheimer disease and frontotemporal lobar degeneration.
    Krüger J; Moilanen V; Majamaa K; Remes AM
    Alzheimer Dis Assoc Disord; 2012; 26(3):272-6. PubMed ID: 21959359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype.
    Thomas Q; Nambot S; Béjot Y; Philippe C; Faivre L; Duffourd Y; Thauvin-Robinet C; Dupont G
    Alzheimer Dis Assoc Disord; 2023 Jan-Mar 01; 37(1):82-84. PubMed ID: 35383591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.
    Zhu Y; Gong L; He C; Wang Q; Ren Q; Xie C;
    J Alzheimers Dis; 2019; 70(3):843-860. PubMed ID: 31282419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional connectivity in autosomal dominant and late-onset Alzheimer disease.
    Thomas JB; Brier MR; Bateman RJ; Snyder AZ; Benzinger TL; Xiong C; Raichle M; Holtzman DM; Sperling RA; Mayeux R; Ghetti B; Ringman JM; Salloway S; McDade E; Rossor MN; Ourselin S; Schofield PR; Masters CL; Martins RN; Weiner MW; Thompson PM; Fox NC; Koeppe RA; Jack CR; Mathis CA; Oliver A; Blazey TM; Moulder K; Buckles V; Hornbeck R; Chhatwal J; Schultz AP; Goate AM; Fagan AM; Cairns NJ; Marcus DS; Morris JC; Ances BM
    JAMA Neurol; 2014 Sep; 71(9):1111-22. PubMed ID: 25069482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of the default mode functional connectivity in normal ageing and Alzheimer's disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements.
    Toussaint PJ; Maiz S; Coynel D; Doyon J; Messé A; de Souza LC; Sarazin M; Perlbarg V; Habert MO; Benali H
    Neuroimage; 2014 Nov; 101():778-86. PubMed ID: 25111470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
    Hoogmartens J; Hens E; Engelborghs S; Vandenberghe R; De Deyn PP; Cacace R; Van Broeckhoven C;
    Neurobiol Aging; 2021 Mar; 99():100.e17-100.e23. PubMed ID: 33023779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.